R14 FAQs
R14 FAQs
The R14 Rapid Genome Sequencing Service is a quick Whole Genome Sequencing test for acutely unwell children and some adults with a likely monogenic disorder, where rapid results are crucial for clinical care. Preliminary results are typically available within two weeks.
The most common method is a gene-agnostic trio analysis, which compares the patient's genome with their parents' genomes. This allows for the identification of a variety of inheritance patterns.
The test has a diagnostic yield of about 38-40% but may not detect certain conditions like methylation abnormalities or some structural rearrangements. Requests for the test must be supported by a Clinical Geneticist.
Relevant Forms and Leaflets:
R14 Patient Result Tracker (Beta)
Date samples expected to be sent by and the patient's location to get key information.